Search Options Stock News and Analysis from Schaeffer's

Dow on the Rise to Start Thanksgiving Week

https://www.schaeffersresearch.com/content/ezines/2020/11/23/dow-on-the-rise-to-start-thanksgiving-week

11/23/2020 11:56 AM

The Dow Jones Industrial Average (DJI) is up over 150 points midday, after AstraZeneca (AZN) became the most recent drug stock to boost the market with upbeat vaccine data. The London-based drugma...

REGN Rises on Quarterly Win, Potential COVID-19 Treatment Approval

https://www.schaeffersresearch.com/content/news/2020/11/05/regn-rises-on-quarterly-win-potential-covid-19-treatment-approval

11/5/2020 3:24 PM

The shares of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) are up 0.3% at $588.86 at last check, after the company reported third-quarter earnings of $8.36 per share -- significantly higher than Wall...

REGN Attracts Options Bulls After Trump Treatment

https://www.schaeffersresearch.com/content/options/2020/10/05/regn-attracts-options-bulls-after-trump-treatment

10/5/2020 1:00 PM

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is getting a boost this afternoon, up 6.7% at $602.62, amid news that U.S. President Donald Trump has been receiving intravenous doses of the pharmaceutical...

REGN Flat Despite COVID-19 Antibody Drug Update

https://www.schaeffersresearch.com/content/news/2020/08/04/regn-flat-despite-covid-19-antibody-drug-update

8/4/2020 10:18 AM

The shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) are trading sideways this morning at $644.66, even though the biotechnology company announced the coronavirus antibody drug it is developing ...

Expedited COVID-19 Trials Give REGN a Boost

https://www.schaeffersresearch.com/content/news/2020/07/06/expedited-covid-19-trials-give-regn-a-boost

7/6/2020 9:41 AM

Biotech Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is getting a boost this morning after news that it's starting phase 3 trials for its antibody drug cocktail to treat COVID-19. This trial comes jus...

PEOPLE ALSO SEARCH FOR

-notable-earning-reports